Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine to prevent MDMA-induced memory impairment in humans
2010-024543-33Phase 4Completed
- Sponsor
- Maastricht University
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Memantine pretreatment + MDMA with Placebo pretreatment + MDMA (2 arms). Primary endpoint: Immediate visual verbal learning recall after pretreatment and MDMA treatment. Started Jan 2011; status: completed.
02
Drugs
memantine
Beyond the preview
Go deeper on 2010-024543-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024543-33.